The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial

DSpace Repository

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial

Author: Sledge, George W.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Conte, PierFranco; Lu, Yi; Barriga, Susana; Hurt, Karla; Frenzel, Martin; Johnston, Stephen; Llombart-Cussac, Antonio
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Jama Oncology (2020), Bd. 6, H. 1, S. 116-124
Verlagsangabe: Amer Medical Assoc
Language: English
Full text: http://dx.doi.org/10.1001/jamaoncol.2019.4782
ISSN: 2374-2445
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Konferenzveröffentlichung
Show full item record

This item appears in the following Collection(s)